Stay updated on MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety
Sign up to get notified when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.

Latest updates to the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page
- Check5 days agoChange DetectedThe web page has updated its version from v2.16.6 to v2.16.8 and added a section on HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check20 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.8%
- Check27 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant announcement regarding the modernization of ClinicalTrials.gov data ingest has been deleted.SummaryDifference0.9%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe expected modernization of the ClinicalTrials.gov data ingest has been postponed from June 2025 to July 2025, and the revision version has been updated from v2.16.2 to v2.16.4.SummaryDifference1.0%
- Check55 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
Stay in the know with updates to MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety
Enter your email address, and we'll notify you when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.